[vc_row][vc_column][vc_column_text]

Pre-Conference Day

Wednesday May 27, 2020
08:00 – 16:45
Palais des Congrès de Paris
Room: TBD

Access for Pre-Conference Day tracks are valid with a Pre-Conference or Conference Bundle registration.

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]Needle to Needle: Cell Processing from Collection to Patient Infusion

Join the journey from ‘Needle to Needle’ as the 2020 Cell Processing Track features a carefully curated program offering a unique look into the production of cell-based products, with a focus on novel processing techniques including gene editing, cell activation and expansion  and characterization by flow cytometry. This practical workshop will provide delegates an opportunity to dig into the details of what it takes to bring a product from bench to bedside.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Gold Sponsors

[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Supporting Organization

[/vc_column_text][vc_empty_space height=”15″][vc_column_text][/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Program

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Session 1: Collection and Starting Materials

Jennifer Webb, MD, MSCE, Children’s National Medical Center, United States

Alexey Bersenev, MD, PhD, Yale University, United States

Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, United States

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”15″][vc_column_text]

Session 2: Selection of Cells and Gene Editing

Ruud Hulspas, PhD, Cellular Technologies Bioconsulting, LLC, Netherlands

Isabelle Riviere, PhD, Memorial Sloan Kettering Cancer Centre, United States

Denise Gavin, PhD, FDA, United States

[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Lunch Presentations

Beckman Coulter

Be The Match BioTherapies

[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Session 3: Cell Activation and Expansion

Alex Cheung, PhD, Immulus, Inc., United States

Shabnum Patel, PhD, Stanford University, United States

Maxime Feyeux, PhD, TreeFrog Therapeutics, France

[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Session 4: ISCT-ISAC Joint Session: Product Characterization

Virginia Litwin, PhD, Caprion Biosciences, Canada

Dianne Kadidlo, MT(ASCP)SBB, University of Minnesota, United States

Andrew Fesnak, MD, University of Pennsylvania, United States 

[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

Organizing Committee

[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Ruud Hulspas, PhD
Cellular Technologies Bioconsulting, LLC
Netherlands
[/vc_column_text][vc_empty_space][/vc_column][vc_column width=”1/2″][vc_column_text]Mara Neal, SH(ASCP)MT, MS, MBA
Cook Biotech
United States
[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Vicki Antonenas, MSc
Westmead Hospital
Australia
[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]Paul Wallace, PhD
Roswell Park Comprehensive Cancer Center
United States
[/vc_column_text][/vc_column][/vc_row]